Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

32.89
+2.568.44%
Post-market: 32.52-0.3738-1.14%18:38 EDT
Volume:336.86K
Turnover:11.03M
Market Cap:215.76M
PE:-2.75
High:34.90
Open:31.26
Low:30.50
Close:30.33
Loading ...

Instil Bio, Inc. : H.c. Wainwright Cuts Target Price to $105 From $110

THOMSON REUTERS
·
22 May

Instil Bio Inc - US Phase 1B/2 Trial of '2510 to Start Before End of 2025

THOMSON REUTERS
·
22 May

Instil Bio Inc - Initial Safety and Efficacy Results Expected in H2 2025

THOMSON REUTERS
·
22 May

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool
·
21 May

Instil Bio Q1 Adj. EPS $(1.32) Beats $(2.59) Estimate

Benzinga
·
13 May

Instil Bio Inc. Reports Increased Net Loss Per Share and Reduced Non-GAAP Net Loss Per Share in Q1 2025 Results

Reuters
·
13 May

BRIEF-Instil Bio Q1 Basic EPS USD -4.32

Reuters
·
13 May

Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
13 May

Instil Bio Q1 Net Income USD -28.2 Million

THOMSON REUTERS
·
13 May

Instil Bio Q1 Basic EPS USD -4.32

THOMSON REUTERS
·
13 May

3 Monster Stocks in the Making

Motley Fool
·
11 May

Instil Bio Inc expected to post a loss of $2.59 a share - Earnings Preview

Reuters
·
06 May

My 3 Favorite Stocks to Buy Right Now

Motley Fool
·
06 May

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

GlobeNewswire
·
03 May

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

GlobeNewswire
·
26 Apr

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

GlobeNewswire
·
24 Apr

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?

Insider Monkey
·
19 Apr

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
19 Apr

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey
·
16 Apr

Here's Why Summit Therapeutics Stock Soared 15% on Friday

Zacks
·
14 Apr